While NK and IgA enhancements suggest immune strengthening, these did not translate to significant infection reductions, possibly due to underpowering (small n = 50), 12-week duration missing seasonal peaks, or the population's relatively mild baseline risk. This evidence concerns the gene CD79A and infection.